We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Scott Gottlieb, the FDA’s deputy commissioner for medical and scientific affairs, and one of the agency’s more public faces, is going back to the private sector in January, the agency announced.
Scott Gottlieb, the FDA’s deputy commissioner for medical and scientific affairs, and one of the agency’s more public faces, is going back to the private sector in January, the agency announced.
The U.S. Justice Department (DOJ) charged former FDA Commissioner Lester Crawford with fraud on Oct. 16 for allegedly lying to HHS about his continued ownership of stocks in companies that the agency regulated.
Sites should look for flexibility when shopping for electronic data capture (EDC) systems and should be aware of the increasing potential for integrating information from electronic medical records (EMRs), according to one prominent vendor.
Leslie Norwalk will serve as acting administrator of the Centers for Medicare & Medicaid Services (CMS) effective Oct. 15, outgoing Administrator Mark McClellan announced in a Sept. 25 email to staff.
Leslie Norwalk will serve as acting administrator of the Centers for Medicare & Medicaid Services (CMS) effective Oct. 15, outgoing Administrator Mark McClellan announced in a Sept. 25 email to staff.
The White House’s pick to run the FDA is again facing opposition, this time from members of the president’s own party, as two Republican lawmakers have threatened to place a hold on the nomination.
In response to a rising number of pediatric clinical trials, the FDA is adding an ethicist to the staff of its Office of Pediatric Therapeutics in an effort to ensure protections for children.